BEIJING SCITOP BIO revenue breakdown overview

BEIJING SCITOP BIO revenue for the last year amounted to 299.12 M CNY, the most of which — 191.67 M CNY — came from its highest performing source at the moment, Edible Probiotic Products, the year earlier bringing 139.53 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING SCITOP BIO 293.72 M CNY, and the year before that — 365.97 M CNY.